Alseres Pharmaceuticals (Alseres Pharmaceuticals) Debt-to-Equity : -0.77 (As of Jun. 2014)

Alseres Pharmaceuticals Debt-to-Equity Chart

Alseres Pharmaceuticals Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Debt-to-Equity		Get a 7-Day Free Trial					-0.75	-0.71	-0.92	-0.85	-0.76

Alseres Pharmaceuticals Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
Debt-to-Equity	Get a 7-Day Free Trial															-0.84	-0.83	-0.76	-0.77	-0.77

Competitive Comparison of Alseres Pharmaceuticals's Debt-to-Equity

For the Biotechnology subindustry, Alseres Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alseres Pharmaceuticals's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alseres Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Alseres Pharmaceuticals's Debt-to-Equity falls into.

Alseres Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Alseres Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Dec. 2013 is calculated as

Alseres Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Jun. 2014 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alseres Pharmaceuticals  (OTCPK:ALSE) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Alseres Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Alseres Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alseres Pharmaceuticals (Alseres Pharmaceuticals) Business Description